Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Bydgoszcz – page 8

726 clinical trials in Bydgoszcz, Poland across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Bydgoszcz at a glance
726
clinical trials
  • Research sites6
Type of trial
Recruitment status
Quick filters

726 trials in Bydgoszcz

Open in trial search

Randomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

Phase 2 Randomized Study of Povetacicept to Assess Safety and Effectiveness in Adults with Generalized Myasthenia Gravis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Vertex Pharmaceuticals Inc.

Crohn's disease

Recruiting

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:C4 Therapeutics Inc.

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

AUR200 for Patients with Generalized Myasthenia Gravis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AUR200

QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Arsenic Trioxide

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Dyslipidaemia

Recruiting

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Graves' disease

Recruiting

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Bydgoszcz

What the registry says about research in the country

01 Respiratory & Infectious Diseases

Innovative clinical trials focusing on respiratory syncytial virus (RSV) and pneumococcal infections in both adults and children. Studies include vaccine development for multiple age groups and assessment of immune responses.

  • RSV and Metapneumovirus Prevention
  • Pneumococcal Vaccine Development
  • COPD Treatment Innovation

Research emphasizes preventive measures and vaccine efficacy across different age groups.

02 Neurological Disorders

Groundbreaking research into neurodegenerative conditions, with particular focus on early intervention strategies for Alzheimer's and Parkinson's disease treatment approaches.

  • Early Alzheimer's Disease
  • Parkinson's Disease Therapeutics
  • Myasthenia Gravis Management

Studies aim to slow disease progression and improve patient outcomes.

03 Autoimmune & Inflammatory Conditions

Comprehensive trials examining new treatments for various inflammatory disorders, including psoriasis, arthritis, and inflammatory bowel diseases.

  • Psoriatic Arthritis
  • Crohn's Disease
  • Atopic Dermatitis

Focus on developing targeted therapies for chronic inflammatory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.